Pfizer (PFE) Q4 2023 Earnings Call Transcript : vimarsana.co

PFE earnings call for the period ending December 31, 2023.

Related Keywords

France , Germany , China , Australia , Japan , Canada , Robyn Karnauskas , Robyn Karnauskas Truist , Steve Scala , Chris Shibutani Goldman Sachs , Kerry Holford , Akash Tewari Jefferies , Chris Boshoff , Chris Schott Jpmorgan , Carter Gould Barclays , Louise Chen , Geoff Meacham , David Risinger Leerink , Terence Flynn Morgan Stanley , David Risinger , Andrew Baum , Louise Chen Cantor Fitzgerald , Chris Schott , Carter Gould , Tim Anderson , America Merrill Lynch , Chris Shibutani , Evan Seigerman , Trung Huynh , Francesca Demartino , Kerry Holford Berenberg , Rd Doug Lankler , Dave Denton , Mohit Bansal , Aamir Malik , Andrew Baum Citi , Mikael Dolsten , Terence Flynn , Akash Tewari , Albert Bourla , Rajesh Kumar , Wells Fargo , Goldman Sachs , European Commission , Tim Anderson Wolfe Research Analyst , Vaccine Technical Committee , Pfizer International , Morgan Stanley , Pfizer , Geoff Meacham Bank , Wolfe Research , Company Analyst , Barclays , Vice President , Chief Investor Relations , Motley Fool Stock Advisor , Stock Advisor , Alexandre De Germay , Chief Executive , Pfizer Oncology Innovation Day , Internal Medicine Metabolic Diseases , Pfizer International Commercial , Chief International Commercial , Vaccine Technical , Scientific Officer , Fast Track , Umer Raffat , Chief Oncology , Fargo Securities , Capital Markets , Commercial Officer , Cantor Fitzgerald , Chief Business , Executive Vice President , Wells Fargo Securities , Berenberg Capital ,